×
返回 Agenda
Session 5: General discussion
Session Chair(s)
Hironobu Saito, PhD
Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Global Oncology Development ~ Industry Management’s Perspectives ~
George Nakayama, MBA, MS
Daiichi Sankyo Co., Ltd., Japan
Senior Adviser
Future Perspectives of Global Oncology Product Creation
Takashi Owa, PhD
Eisai Co., Ltd., Japan
Senior Corporate Officer, Chief Scientific Officer
Oncology Drug Development and Regulatory Evolution in the Era of Precision Medicine in Japan
Yasuhiro Fujiwara, MD, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Executive